NCT01065779View on ClinicalTrials.gov

FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

CompletedOBSERVATIONAL
Enrollment

880

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Osteoporosis
Interventions
DRUG

FOSAMAX PLUS

Patients with Osteoporosis treated with FOSAMAX PLUS (70 mg alendronate/2800 International Units (IU) Vitamin D). One tablet taken once weekly.

DRUG

FOSAMAX PLUS D

Patients with Osteoporosis treated with FOSAMAX PLUS D (70 mg alendronate/5600 IU Vitamin D). One tablet taken once weekly.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01065779 - FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267) | Biotech Hunter | Biotech Hunter